Philip J. Burke

6.0k total citations · 1 hit paper
109 papers, 4.8k citations indexed

About

Philip J. Burke is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Philip J. Burke has authored 109 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 26 papers in Oncology and 26 papers in Hematology. Recurrent topics in Philip J. Burke's work include Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (17 papers) and Cancer therapeutics and mechanisms (16 papers). Philip J. Burke is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (17 papers) and Cancer therapeutics and mechanisms (16 papers). Philip J. Burke collaborates with scholars based in United States, United Kingdom and Netherlands. Philip J. Burke's co-authors include Judith E. Karp, Anthony W. Addison, Rein Saral, Scott H. Kaufmann, David R. McMillin, Steven D. Gore, Ebun Eno‐Amooquaye, William P. Vaughan, Phyllis A. Svingen and Stan Krajewski and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Philip J. Burke

109 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis of some imidazole‐ and pyrazole‐ derived chelating agents

1981 302 citations Philip J. Burke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip J. Burke United States	35	1.8k	1.6k	1.3k	560	529	109	4.8k
Christopher R. Chitambar United States	36	1.5k 0.8×	1.3k 0.8×	688 0.5×	474 0.8×	236 0.4×	117	4.5k
Richard J. Jones United States	30	1.2k 0.6×	821 0.5×	957 0.8×	306 0.5×	240 0.5×	116	4.1k
Kenneth R. Harrap United Kingdom	33	1.9k 1.0×	2.3k 1.4×	309 0.2×	963 1.7×	312 0.6×	108	4.3k
Kees Nooter Netherlands	52	3.9k 2.2×	5.4k 3.4×	953 0.8×	428 0.8×	419 0.8×	149	9.1k
Raymond L. Blakley United States	46	4.4k 2.4×	758 0.5×	390 0.3×	553 1.0×	640 1.2×	161	6.4k
Irwin H. Krakoff United States	32	1.5k 0.8×	1.7k 1.0×	388 0.3×	383 0.7×	483 0.9×	124	4.5k
O. Michael Colvin United States	42	2.5k 1.4×	1.9k 1.2×	1.8k 1.4×	228 0.4×	621 1.2×	124	7.0k
Michael Hayes United States	33	1.2k 0.6×	574 0.4×	1.2k 1.0×	294 0.5×	164 0.3×	97	4.1k
Zahid H. Siddik United States	39	3.8k 2.1×	4.6k 2.9×	396 0.3×	1.3k 2.3×	339 0.6×	154	9.4k
Simon P. Fricker United Kingdom	31	1.2k 0.7×	2.8k 1.8×	502 0.4×	1.1k 2.0×	147 0.3×	81	4.9k

Countries citing papers authored by Philip J. Burke

Since Specialization

Citations

This map shows the geographic impact of Philip J. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Burke more than expected).

Fields of papers citing papers by Philip J. Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Burke. The network helps show where Philip J. Burke may publish in the future.

Co-authorship network of co-authors of Philip J. Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Burke. A scholar is included among the top collaborators of Philip J. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Burke. Philip J. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daccarett, Marcos, Philip J. Burke, & Samir Saba. (2005). Incidental finding of a large pulmonary valve fibroelastoma: A case report. European Journal of Echocardiography. 7(3). 253–256. 13 indexed citations

Jennings, S. A., Shane Roller, Natalie Brooks, et al.. (2001). EFFICIENT SYNTHESIS OF (±)-seco-CYCLOPROPANEINDOLINE ANALOGS OF CC-1065. Heterocyclic Communications. 7(1). 7–16. 3 indexed citations

Sagnou, Marina, Philip W. Howard, Stephen J. Gregson, et al.. (2000). Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT. Bioorganic & Medicinal Chemistry Letters. 10(18). 2083–2086. 23 indexed citations

Svingen, Phyllis A., Judith E. Karp, Stan Krajewski, et al.. (2000). Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. Blood. 96(12). 3922–3931. 44 indexed citations

Bagshawe, Kenneth D., Philip J. Burke, Richard J. Knox, Roger G. Melton, & Surinder K. Sharma. (1999). Targeting enzymes to cancers - new developments. Expert Opinion on Investigational Drugs. 8(2). 161–172. 6 indexed citations

Keawpradub, Niwat, Ebun Eno‐Amooquaye, Philip J. Burke, & Peter J. Houghton. (1999). Cytotoxic Activity of Indole Alkaloids from Alstonia macrophylla. Planta Medica. 65(4). 311–315. 79 indexed citations

Kaufmann, Scott H., Judith E. Karp, Philip J. Burke, & Steven D. Gore. (1996). Addition of Etoposide to Initial Therapy of Adult Acute Lymphoblastic Leukemia: A Combined Clinicaland Laboratory Study. Leukemia & lymphoma. 23(1-2). 71–83. 11 indexed citations

Sharma, Surinder K., Joan A. Boden, Caroline J. Springer, Philip J. Burke, & Kenneth D. Bagshawe. (1994). Antibody-directed enzyme prodrug therapy (ADEPT). Cell Biophysics. 24-25(1-3). 219–228. 26 indexed citations

Bonnett, Raymond, et al.. (1993). The 2,3-secochlorin-2,3-dione system. Journal of the Chemical Society Chemical Communications. 1860–1861. 39 indexed citations

10.

Miller, Carole B., et al.. (1991). Evolution of a near-triploid karyotype in a secondary erythroleukemia. Cancer Genetics and Cytogenetics. 54(1). 11–20. 2 indexed citations

11.

Springer, Caroline J., Kenneth D. Bagshawe, Surinder K. Sharma, et al.. (1991). Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. European Journal of Cancer and Clinical Oncology. 27(11). 1361–1366. 86 indexed citations

12.

Guyer, David R., Andrew Schachat, Susan Vitale, et al.. (1989). Leukemic Retinopathy. Ophthalmology. 96(6). 860–864. 65 indexed citations

13.

Rowinsky, Eric K., Philip J. Burke, Judith E. Karp, et al.. (1989). Phase I and pharmacodynamic study of taxol in refractory acute leukemias.. PubMed. 49(16). 4640–7. 162 indexed citations

14.

Mitchell, R. Brian, Judith E. Karp, Saul W. Brusilow, et al.. (1988). Syndrome of Idiopathic Hyperammonemia after High-Dose Chemotherapy: Review of Nine Cases. The American Journal of Medicine. 85(5). 662–667. 74 indexed citations

15.

Karp, Judith E., William G. Merz, Barbara E. Laughon, et al.. (1987). Oral Norfloxacin for Prevention of Gram-Negative Bacterial Infections in Patients with Acute Leukemia and Granulocytopenia. Annals of Internal Medicine. 106(1). 1–7. 187 indexed citations

16.

Burke, Philip J., et al.. (1976). The Division of Personnel Preparation: How Funding Priorities Are Established and a Personal Assessment of the Impact of PL 94-142.. Education and training of the mentally retarded. 1 indexed citations

17.

Burke, Philip J., R. W. Matthews, & Duncan G. Gillies. (1976). The influence of anion, solvent and concentration on the thallium-205, carbon-13 and proton NMR parameters of the dimethylthallium(III) ion. Journal of Organometallic Chemistry. 118(2). 129–134. 16 indexed citations

18.

Burke, Philip J. & Albert H. Owens. (1971). Attempted recruitment of leukemic myeloblasts to proliferative activity by sequential drug treatment. Cancer. 28(4). 830–836. 47 indexed citations

19.

Burke, Philip J., et al.. (1968). A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).. PubMed. 28(2). 274–9. 25 indexed citations

20.

Burke, Philip J.. (1951). County B.C.G. Campaign. BMJ. 2(4736). 887–889. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact